logo image
☰ search icon
Cell and Gene Therapy Supply Chain Logistics Market

Cell and Gene Therapy Supply Chain/Logistics Market Size, Share & Trends Analysis Report By Application area, By Type of software solution, By Mode of Deployment, By End-user (Biobank, Cell therapy lab, Hospital, Research institute, Commercial organization) , By Region, And By Segment Forecasts, 2024-2031

Report ID : 1694 | Published : 2024-04-24 | Pages: 180 | Format: PDF/EXCEL

Share

The Cell and Gene Therapy Supply Chain/Logistics Market Size is valued at 1.35 Billion in 2023 and is predicted to reach 3.17 Billion by the year 2031 at a 11.41 % CAGR during the forecast period for 2024-2031.

cell and gene

Global Cell and Gene Therapy Supply Chain/Logistics provides customizable services to support any stage of the supply chain, from the point of patient identification through cell harvest, therapeutic intervention, and long-term outcomes data collection. Cell and gene therapies are spearheading a new era in medicine, offering treatments specifically designed to target individual patients' needs. As therapies become more personalized, the need for robust and adaptable supply chain services is skyrocketing. From the procurement of patient-specific materials to the delivery of customized treatments, supply chain services are adapting to ensure seamless coordination of these complex processes. Providing personalized therapeutics along with smart packaging is a key challenge in this market.

Competitive Landscape:

  • Be The Match BioTherapies
  • MAK-SYSTEM
  • Cryoport
  • Brooks Life Sciences
  • Lykan Bioscience
  • Clarkston Consulting
  • SAP
  • Hypertrust Patient Data Care
  • Haemonetics
  • MasterControl
  • TraceLink
  • SAVSU Technologies
  • TrakCel
  • Title21 Health Solutions
  • sedApta Group
  • Vineti
  • Stafa Cellular Therapy
  • Thermo Fisher Scientific(Patheon)
  • McKesson
  • Biocair
  • Marken(UPS Company)
  • Modality Solutions
  • Almac
  • Arvato Supply Chain Solutions SE
  • Catalent, Inc
  • BioLife Solutions, Inc
  • Biostor Ltd
  • Yourway Biopharma Services Company
  • Atelerix Ltd
  • Other Prominent Players

The challenges and needs of cell and gene therapy supply chains increase the need for more advanced IT systems. Most pharmaceutical companies are collaborating with IT companies to make services automated and less complex. Modern technology platforms for supply chain data management can help you control, manage, and monitor your supply chains in just a few clicks. For instance, Marken is developing technologies designed to address complex logistics and provide optimal supply chain solutions for the fast-growing cell and gene therapies market. The constant improvements in the cell and gene therapy (CGT) supply chain management services are expected to propel the Cell and Gene Therapy Supply Chain/Logistics market growth over the forecast period.

The increasing need for cell and gene therapies, developments in the real-time supply chain operations, and the rising number of clinical trials is likely to evolve the Cell and Gene Therapy Supply Chain/Logistics market at a considerable rate in the next few years. Furthermore, advanced medical technologies, increasing customizable facilities, improving quality and efficacy of CGT supply chain services, and novel supply chain service innovations by pharmaceutical companies enhance the market growth. However, the high investment cost required for CGT supply chain services, lack of standard therapy protocols, and complex procedures hinder the market growth.

Market Segmentation

Segmentation of Cell and Gene Therapy Supply Chain/Logistics market includes Application area (Donor eligibility assessment, Sample collection, Manufacturing, Logistics, Patient verification and treatment follow-up), Type of software solution (Cell orchestration platform, Enterprise manufacturing system, Inventory management system, Laboratory information management system, Logistics management system, Patient management system, Quality management system, Tracking and tracing system), Mode of Deployment (Cloud-based solution, On-premises solution), End-user (Biobank, Cell therapy lab, Hospital, Research institute, Commercial organization). Regionally, the Cell and Gene Therapy Supply Chain/Logistics market can be divided into North America, Europe, Latin America, Asia-Pacific, and the Middle East and Africa. North America, followed by Europe, holds the maximum share of this market due to increased research and development expenditure, improved CGT supply chain services efficiency, and the fast adoption of advanced technologies.

Recent Development

  • In June 2023, RoslinCT and Lykan Bioscience, prominent CDMOs in the Cell and Gene Therapy sector, have merged to form a consolidated enterprise that will function under the RoslinCT name. The integration, overseen by GHO Capital, a worldwide investment business, seeks to build a leading participant in the Advanced Cell and Gene Therapy Contract Development and Manufacturing Organization (CDMO) sector.
  • In October 2023, Be The Match BioTherapies and Cryoport announced a new strategic partnership. The collaboration will expand the capabilities of IntegriCell™, a standardized bioprocessing, cryopreservation and distribution solution for the global cell therapy market. With cryopreservation facilities in the U.S. and EU, IntegriCell™ is poised to support decentralized and centralized manufacturing models, enabling and accelerating patient access to innovative new therapies.

 

Cell and Gene Therapy Supply Chain/Logistics Market Report Scope:

Report Attribute

Specifications

Market Size Value In 2023

USD 1.35 Billion

Revenue Forecast In 2031

USD 3.17 Billion

Growth Rate CAGR

CAGR of 11.41 % from 2024 to 2031

Quantitative Units

Representation of revenue in US$ Billion and CAGR from 2024 to 2031

Historic Year

2019 to 2023

Forecast Year

2024-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

Application area, Type of software solution, Mode of Deployment, End-user

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia

Competitive Landscape

Be The Match BioTherapies, MAK-SYSTEM, Cryoport, Brooks Life Sciences, Lykan Bioscience, Clarkston Consulting, SAP, Hypertrust Patient Data Care, Haemonetics, MasterControl, TraceLink, SAVSU Technologies, TrakCel, Title21 Health Solutions, sedApta Group, Vineti, Stafa Cellular Therapy, Thermo Fisher Scientific(Patheon), McKesson, Biocair, Marken(UPS Company), Modality Solutions, Almac, Arvato Supply Chain Solutions SE, Catalent, Inc, BioLife Solutions, Inc, Biostor Ltd, Yourway Biopharma Services Company, Atelerix Ltd

Customization Scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing And Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Cell and Gene Therapy Supply Chain/Logistics Market Snapshot

Chapter 4. Global Cell and Gene Therapy Supply Chain/Logistics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: By Application Area Estimates & Trend Analysis
5.1. By Applications & Market Share, 2019 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Application Area:

5.2.1. Donor eligibility assessment
5.2.2. Sample collection
5.2.3. Manufacturing
5.2.4. Logistics
5.2.5. Patient verification and treatment follow-up

Chapter 6. Market Segmentation 1: By Type of Software Solution Estimates & Trend Analysis
6.1. By Applications & Market Share, 2019 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Type of Software Solution:

6.2.1. Cell orchestration platform
6.2.2. Enterprise manufacturing system
6.2.3. Inventory management system
6.2.4. Laboratory information management system
6.2.5. Logistics management system
6.2.6. Patient management system
6.2.7. Quality management system
6.2.8. Tracking and tracing system

Chapter 7. Market Segmentation 1: By End-User Estimates & Trend Analysis
7.1. By Applications & Market Share, 2019 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By End-User:

7.2.1. Biobank
7.2.2. Cell Therapy Lab
7.2.3. Hospital
7.2.4. Research Institute
7.2.5. Commercial Organization

Chapter 8. Market Segmentation 2: By Mode of Deployment Estimates & Trend Analysis
8.1. By Types & Market Share, 2019 & 2031
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Mode of Deployment:

8.2.1. Cloud
8.2.2. On-premises

Chapter 9. Cell and Gene Therapy Supply Chain/Logistics Market Segmentation 3: Regional Estimates & Trend Analysis

9.1. North America

9.1.1. North America Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts By Application Area, 2024-2031
9.1.2. North America Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts By Type of Software Solution, 2024-2031
9.1.3. North America Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts By End-User, 2024-2031
9.1.4. North America Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts by Mode of Deployment, 2024-2031
9.1.5. North America Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts by country, 2024-2031

9.2. Europe

9.2.1. Europe Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts By Application Area, 2024-2031
9.2.2. Europe Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts By Type of Software Solution, 2024-2031
9.2.3. Europe Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) By End-User, 2023-2031
9.2.4. Europe Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts by Mode of Deployment, 2024-2031
9.2.5. Europe Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) by country, 2024-2031

9.3. Asia Pacific

9.3.1. Asia Pacific Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts By Application Area, 2024-2031
9.3.2. Asia Pacific Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts By Type of Software Solution, 2024-2031
9.3.3. Asia Pacific Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) By End-User, 2024-2031
9.3.4. Asia Pacific Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts by Mode of Deployment, 2024-2031
9.3.5. Asia Pacific Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) by country, 2024-2031

9.4. Latin America

9.4.1. Latin America Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts By Application Area, 2024-2031
9.4.2. Latin America Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts By Type of Software Solution, 2024-2031
9.4.3. Latin America Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) By End-User, (US$ Million)
9.4.4. Latin America Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts by Mode of Deployment, 2024-2031
9.4.5. Latin America Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) by country, 2024-2031

9.5. Middle East & Africa

9.5.1. Middle East & Africa Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts By Application Area, 2024-2031
9.5.2. Middle East & Africa Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts By Type of Software Solution, 2024-2031
9.5.3. Middle East & Africa Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) By End-User, (US$ Million)
9.5.4. Middle East & Africa Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts by Mode of Deployment, 2024-2031
9.5.5. Middle East & Africa Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) by country, 2024-2031 

Chapter 10. Competitive Landscape

10.1. Major Mergers and Acquisitions/Strategic Alliances

10.2. Company Profiles


10.2.1. Be The Match BioTherapies
10.2.2. MAK-SYSTEM
10.2.3. Cryoport
10.2.4. Brooks Life Sciences
10.2.5. Lykan Bioscience
10.2.6. Clarkston Consulting
10.2.7. SAP
10.2.8. Hypertrust Patient Data Care
10.2.9. Haemonetics
10.2.10. MasterControl
10.2.11. TraceLink
10.2.12. SAVSU Technologies
10.2.13. TrakCel
10.2.14. Title21 Health Solutions
10.2.15. sedApta Group
10.2.16. Vineti
10.2.17. Stafa Cellular Therapy
10.2.18. Thermo Fisher Scientific(Patheon)
10.2.19. McKesson
10.2.20. Biocair
10.2.21. Marken(UPS Company)
10.2.22. Modality Solutions
10.2.23. Almac
10.2.24. Arvato Supply Chain Solutions SE
10.2.25. Catalent, Inc
10.2.26. BioLife Solutions, Inc
10.2.27. Biostor Ltd
10.2.28. Yourway Biopharma Services Company
10.2.29. Atelerix Ltd
10.2.30. Other Prominent Players

Market Segmentation:

Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Application Area

  • Donor eligibility assessment
  • Sample collection
  • Manufacturing
  • Logistics
  • Patient verification and treatment follow-up

cell and gene

Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Type of Software Solution

  • Cell orchestration platform
  • Enterprise manufacturing system
  • Inventory management system
  • Laboratory information management system
  • Logistics management system
  • Patient management system
  • Quality management system
  • Tracking and tracing system

Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on End-User

  • Biobank
  • Cell Therapy Lab
  • Hospital
  • Research Institute
  • Commercial Organization

 

Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Type of Deployment

  • Cloud-Based
  • On-premises

Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa 

North America Cell and Gene Therapy Supply Chain/Logistics market revenue (US$ Million) by Country, 2023 to 2031

  • U.S.
  • Canada

Europe Cell and Gene Therapy Supply Chain/Logistics market revenue (US$ Million) by Country, 2023 to 2031

  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific Cell and Gene Therapy Supply Chain/Logistics market revenue (US$ Million) by Country, 2023 to 2031

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America Cell and Gene Therapy Supply Chain/Logistics market revenue (US$ Million) by Country, 2023 to 2031

  • Brazil
  • Mexico
  • Rest of Latin America 

Middle East & Africa Cell and Gene Therapy Supply Chain/Logistics market revenue (US$ Million) by Country, 2023 to 2031

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa 

Competitive Landscape

  • Company Overview
  • Financial Performance
  • Key Development
  • Latest Strategic Developments

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the Cell and Gene Therapy Supply Chain/Logistics Market?

Cell and Gene Therapy Supply Chain/Logistics Market is expected to grow at an 1141 % CAGR during the forecast period for 2024-2031

Be The Match BioTherapies, MAK-SYSTEM, Cryoport, Brooks Life Sciences, Lykan Bioscience, Clarkston Consulting, SAP, Hypertrust Patient Data Care

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Pharmaceuticals

Select Licence Type
$4456
$7786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach
Related Reports
logo

Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses.

  • facebook icon
  • twitter icon
  • linkedin icon
Category
Quick Links
Office Address